128 related articles for article (PubMed ID: 35199613)
1. WAGR, Sex Reversal, Bilateral Gonadoblastomas, and Intralobar Nephrogenic Rests: Uncertainties of Pre-Biopsy Chemotherapy in a High Risk Syndrome for Nephroblastoma.
Craver R; Stark M; Moss S; Long S; Prasad P; C Roth C
Fetal Pediatr Pathol; 2023 Feb; 42(1):63-71. PubMed ID: 35199613
[No Abstract] [Full Text] [Related]
2. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
Charles AK; Brown KW; Berry PJ
Am J Pathol; 1998 Sep; 153(3):991-1000. PubMed ID: 9736048
[TBL] [Abstract][Full Text] [Related]
3. Nephrogenic rests in Wilms tumor patients with the Drash syndrome.
Heppe RK; Koyle MA; Beckwith JB
J Urol; 1991 Jun; 145(6):1225-8. PubMed ID: 1851891
[TBL] [Abstract][Full Text] [Related]
4. WT1 deletion leading to severe 46,XY gonadal dysgenesis, Wilms tumor and gonadoblastoma: case report.
Finken MJ; Hendriks YM; van der Voorn JP; Veening MA; Lombardi MP; Rotteveel J
Horm Res Paediatr; 2015; 83(3):211-6. PubMed ID: 25613702
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.
Park S; Bernard A; Bove KE; Sens DA; Hazen-Martin DJ; Garvin AJ; Haber DA
Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644
[TBL] [Abstract][Full Text] [Related]
6. Single-nucleotide polymorphism in WT1 gene in a hyperplastic intralobar nephrogenic rest with botryoid protrusion.
Mizuno K; Hayashi Y; Tozawa K; Iwatsuki S; Kojima Y; Kohri K
Urology; 2010 Jul; 76(1):149-52. PubMed ID: 19914700
[TBL] [Abstract][Full Text] [Related]
7. Renal pathology in WAGR syndrome.
Ariel I; Abeliovich D; Bar-ziv J; Hochberg A
Pediatr Pathol Lab Med; 1996; 16(6):1013-21. PubMed ID: 9025899
[TBL] [Abstract][Full Text] [Related]
8. Nephrogenic rests and the pathogenesis of Wilms tumor: developmental and clinical considerations.
Beckwith JB
Am J Med Genet; 1998 Oct; 79(4):268-73. PubMed ID: 9781906
[TBL] [Abstract][Full Text] [Related]
9. Wilms tumor: an update.
Al-Hussain T; Ali A; Akhtar M
Adv Anat Pathol; 2014 May; 21(3):166-73. PubMed ID: 24713986
[TBL] [Abstract][Full Text] [Related]
10. Bilateral gonadoblastoma with dysgerminoma and pilocytic astrocytoma with WT1 GT-IVS9 mutation: A 46 XY phenotypic female with Frasier syndrome.
Subbiah V; Huff V; Wolff JE; Ketonen L; Lang FF; Stewart J; Langford L; Herzog CE
Pediatr Blood Cancer; 2009 Dec; 53(7):1349-51. PubMed ID: 19653292
[TBL] [Abstract][Full Text] [Related]
11. An unusual phenotype of Frasier syndrome due to IVS9 +4C>T mutation in the WT1 gene: predominantly male ambiguous genitalia and absence of gonadal dysgenesis.
Melo KF; Martin RM; Costa EM; Carvalho FM; Jorge AA; Arnhold IJ; Mendonca BB
J Clin Endocrinol Metab; 2002 Jun; 87(6):2500-5. PubMed ID: 12050205
[TBL] [Abstract][Full Text] [Related]
12. A 46,XY female DSD patient with bilateral gonadoblastoma, a novel SRY missense mutation combined with a WT1 KTS splice-site mutation.
Hersmus R; van der Zwan YG; Stoop H; Bernard P; Sreenivasan R; Oosterhuis JW; Brüggenwirth HT; de Boer S; White S; Wolffenbuttel KP; Alders M; McElreavy K; Drop SL; Harley VR; Looijenga LH
PLoS One; 2012; 7(7):e40858. PubMed ID: 22815844
[TBL] [Abstract][Full Text] [Related]
13. Genotype/phenotype correlation in nephrotic syndrome caused by WT1 mutations.
Chernin G; Vega-Warner V; Schoeb DS; Heeringa SF; Ovunc B; Saisawat P; Cleper R; Ozaltin F; Hildebrandt F;
Clin J Am Soc Nephrol; 2010 Sep; 5(9):1655-62. PubMed ID: 20595692
[TBL] [Abstract][Full Text] [Related]
14. Sequential WT1 and CTNNB1 mutations and alterations of beta-catenin localisation in intralobar nephrogenic rests and associated Wilms tumours: two case studies.
Fukuzawa R; Heathcott RW; More HE; Reeve AE
J Clin Pathol; 2007 Sep; 60(9):1013-6. PubMed ID: 17172473
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric Oncology.
Royer-Pokora B; Weirich A; Schumacher V; Uschkereit C; Beier M; Leuschner I; Graf N; Autschbach F; Schneider D; von Harrach M
Cancer; 2008 Sep; 113(5):1080-9. PubMed ID: 18618575
[TBL] [Abstract][Full Text] [Related]
16. Complete sex reversal in a WAGR syndrome patient.
Le Caignec C; Delnatte C; Vermeesch JR; Boceno M; Joubert M; Lavenant F; David A; Rival JM
Am J Med Genet A; 2007 Nov; 143A(22):2692-5. PubMed ID: 17935232
[TBL] [Abstract][Full Text] [Related]
17. Responsiveness of chemotherapy based on the histological type and Wilms' tumor suppressor gene mutation in bilateral Wilms' tumor.
Shibata R; Takata A; Hashiguchi A; Umezawa A; Yamada T; Hata J
Pathol Int; 2003 Apr; 53(4):214-20. PubMed ID: 12675764
[TBL] [Abstract][Full Text] [Related]
18. [Disorders of sex development 46 XY and bilateral metachronous wilms tumor in a child with mutation in exon 7 of WT1 gene].
Akramov NR; Osipova IV; Zakirov AK; Khaertdinov EI
Urologiia; 2019 Dec; (6):109-112. PubMed ID: 32003178
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic bilateral nephrectomies in two paediatric patients with missense mutations in the WT1 gene.
Hu M; Zhang GY; Arbuckle S; Graf N; Shun A; Silink M; Lewis D; Alexander SI
Nephrol Dial Transplant; 2004 Jan; 19(1):223-6. PubMed ID: 14671061
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for end stage renal disease in non-WT1-syndromic Wilms tumor.
Lange J; Peterson SM; Takashima JR; Grigoriev Y; Ritchey ML; Shamberger RC; Beckwith JB; Perlman E; Green DM; Breslow NE
J Urol; 2011 Aug; 186(2):378-86. PubMed ID: 21683387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]